Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.27    -0.06 (-2.58%)
Bid:
2.24
Ask:
2.30
Spread: 0.06 (2.679%)
Market Cap: £12.31m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

Completion of Subscription

17 Nov 2025 07:00

RNS Number : 6946H
Valereum PLC
17 November 2025
 

17/11/25

 

Valereum Plc

("Valereum", "VLRM" or the "Company")

 

Completion of £0.6m Subscription, Director Dealings and Grant of Warrants

Valereum Plc (AQSE: VLRM) announces that the Company has successfully completed the subscription to raise £0.6m as previously announced on 10 October 2025 (the "Subscription"). The raise comprised £0.225m from its Chairman, James Bannon, £0.225m from its Group CEO, Gary Cottle, and £0.15m from an unconnected party through the issuance of 12,000,000 new Ordinary Shares of £0.001 each at a subscription price of £0.05 per share (the "Subscription Shares").

In connection with the Subscription, both James Bannon and Gary Cottle have been issued 2,500,000 warrants each at an exercise price of £0.50 per warrant and 2,500,000 warrants each at an exercise price of £1.00 per warrant. The unconnected party has been issued 1,666,667 warrants at an exercise price of £0.50 per warrant plus 1,666,667 warrants at an exercise price of £1.00 per warrant. The warrants will vest immediately and will be exercisable over a period of 5 years from the issue date.

 

Admission

 

Application will be made for the 12,000,000 Subscription Shares, which will rank pari passu with the existing Ordinary Shares in issue, to be admitted to trading on the AQSE Growth Market ("Admission"). Dealings are expected to commence on or around 19 November 2025 and the issue is subject only to Admission.

 

Total voting rights

 

Following Admission, the Company's issued share capital will comprise 243,204,304 Ordinary Shares of £0.001 each, all carrying voting rights. This figure may be used by shareholders as the denominator for the calculation to determine if they are required to notify the Company of their interest in, or a change to their interest in, the Company's securities.

As previously announced, the proceeds are intended to be used to fund the scale-up of VLRM Markets through accelerating the build of an institutional-grade regulated footprint across global jurisdictions, enhancing distribution reach through strategic partnerships and collaborations, as well as expanding the utility of GATE Token across the Valereum ecosystem.

The FCA notifications, made in accordance with the requirements of the UK Market Abuse Regulation, are appended below.

The Directors of the Company accept responsibility for the contents of this announcement.

 

For further information, please contact:

 

Valereum Plc

Karl Moss

 

Tel: +44 7938 767319  Investor Hub

Fortified Securities

Guy Wheatley

 

Tel: +44 203 4117773

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge 

 

 

Tel: +44 20 3855 5551

 

To read more, please visit the Company's website at www.vlrm.com 

or

To engage with Valereum directly by asking questions, watching videosummaries and seeing what other shareholders have to say, navigate to our Investor Hub here: Sign Up

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR CONNECTED PERSONS

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Bannon

2.

Reason for the Notification

a)

Position/status

Executive Chairman

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Valereum Plc

b)

LEI

213800EJ8BFEQQ9POX79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Subscription of ordinary shares

c)

Price(s) and volume(s)

 

Price

Volume

£0.05 per Ordinary Share

4,500,000

d)

Aggregated information:

·Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

14 November 2025

f)

Place of the Transaction

Outside a trading venue

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Grant of warrants over ordinary shares

c)

Price(s) and volume(s)

 

Exercise price

Volume

1. Exercise price of £0.50 per warrant

 

2. Exercise price of £1.00 per warrant

1. 2,500,000

 

 

2. 2,500,000

d)

Aggregated information:

·Aggregated volume

· Price

 

5,000,000

£0.75

e)

Date of the transaction

14 November 2025

f)

Place of the Transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gary Cottle

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Valereum Plc

b)

LEI

213800EJ8BFEQQ9POX79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Subscription of ordinary shares

c)

Price(s) and volume(s)

 

Price

Volume

£0.05 per Ordinary Share

4,500,000

d)

Aggregated information:

· Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

14 November 2025

f)

Place of the Transaction

Outside a trading venue

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Grant of warrants over ordinary shares

c)

Price(s) and volume(s)

 

Exercise price

Volume

3. Exercise price of £0.50 per warrant

 

4. Exercise price of £1.00 per warrant

3. 2,500,000

 

 

4. 2,500,000

d)

Aggregated information:

·Aggregated volume

· Price

 

5,000,000

£0.75

e)

Date of the transaction

14 November 2025

f)

Place of the Transaction

Outside a trading venue

 

 

 

 

IMPORTANT NOTICES

 

The Company holds cryptocurrencies or cryptoassets in its treasury. Whilst the Board of Directors of the Company considers holding cryptocurrencies to be in the best interests of the Company, the Board remains aware that the financial regulator in the UK (the Financial Conduct Authority or FCA) considers investment in cryptocurrencies to be high risk. At the outset, it is important to note that an investment in the Company is not an investment in cryptocurrencies, either directly or by proxy and shareholders will have no direct access to the Company's holdings. However, the Board of Directors consider cryptocurrencies to be an appropriate store of value and potential growth and therefore appropriate for the Company. Accordingly, the Company is and intends to continue to be materially exposed to cryptocurrencies.

 

The Company is neither authorised nor regulated by the FCA, and the purchase of certain cryptocurrencies are generally unregulated in the UK. As with most other investments, the value of cryptocurrencies can go down as well as up, and therefore the value of the Company's cryptocurrencies holdings can fluctuate. The Company may not be able to realise its cryptocurrencies holdings for the same as it paid to acquire them or even for the value the Company currently ascribes to its cryptocurrencies positions due to market movements. Neither the Company nor investors in the Company's shares are protected by the UK's Financial Ombudsman Service or the Financial Services Compensation Scheme. 

 

Cryptocurrencies may present special risks to the Company's financial position. These risks include (but are not limited to): (i) the value of cryptocurrencies can be highly volatile, with value dropping as quickly as it can rise. Investors in cryptocurrencies must be prepared to lose all money invested in cryptocurrencies; (ii) the cryptocurrencies market is largely unregulated. There is a risk of losing money due to risks such as cyber-attacks, financial crime and counterparty failure; (iii) the Company may not be able to sell its cryptocurrencies at will. The ability to sell cryptocurrencies depends on various factors, including the supply and demand in the market at the relevant time. Operational failings such as technology outages, cyber-attacks and comingling of funds could cause unwanted delay; and (iv) cryptoassets are characterised in some quarters by high degrees of fraud, money laundering and financial crime. Prospective investors in the Company are encouraged to do their own research before investing. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAKFKFDASFFA
Date   Source Headline
8th Aug 202511:29 amRNSUpdate on Retail Offer
4th Aug 20257:00 amRNSSubscription and Director Dealings
1st Aug 20257:08 amRNS£0.5m Fundraise and Establishment of BTC Treasury
29th Jul 20257:00 amRNSReduction of Holding in London BTC Company Limited
29th Jul 20257:00 amRNSHolding(s) in Company
14th Jul 20257:00 amRNS-RNon-binding MoU with First Class Metals Plc
7th Jul 20254:25 pmRNSResult of AGM
3rd Jul 20255:35 pmRNSBoard Appointments, Exercise and Issue of Warrants
30th Jun 20255:06 pmRNSAnnual Accounts
18th Jun 20257:00 amRNSValereum Plc Announces New CEO
16th Jun 20257:00 amRNSStrategic Investment in Fideum Group Limited
11th Jun 20257:00 amRNSBoard Changes and Proposed Appointments
10th Jun 202510:00 amRNSValereum Plc Announces AGM 2025
9th Jun 20257:00 amRNS-R‘The Bridge’ V1 DFMI is now Demo Ready
5th Jun 20257:00 amRNSMemorandum of Understanding with Fideum
3rd Jun 20257:05 amRNS£500K Placing with Fortified Securities
3rd Jun 20257:00 amRNSStrategic Investment in Blubird Global
30th May 20257:00 amRNSValereum Signs MoU with Blubird Global Inc
29th May 20254:53 pmRNS-RTokenisation Partnership Agreement
29th May 202510:00 amRNS-RValereum Announces the Go-Live of VLRM Markets
20th May 202510:46 amRNSValereum PLC Invests in DigiShares
15th May 20252:59 pmRNS-RVLRM Markets to Launch Digital Asset Services
8th May 20257:00 amRNSPlacing of £0.5 Million via Clear Capital Markets
25th Apr 20257:00 amRNS-REl Salvador delegation & SEC discuss collaboration
24th Apr 20253:43 pmRNS-RVLRM Markets to Commence Operations
22nd Apr 202512:03 pmRNSDMC Deal Update
9th Apr 20253:53 pmRNSCompletion Update
7th Mar 20252:08 pmRNSDeal Completion Update
20th Feb 20257:52 amRNSBinding Heads of Terms for £19m Capital Raise
14th Feb 20254:29 pmRNSUpdate on Option Agreement
11th Feb 202511:12 amRNS-RParticipation in Maxim Group’s Virtual Conference
4th Feb 20253:54 pmRNS-RLaunch of Interactive Investor Hub
4th Feb 20251:54 pmRNSExercise of Warrants
31st Jan 20254:15 pmRNSValereum Provides Update on DMC Investment Deal
2nd Jan 202511:43 amRNSExercise of £2m Option Agreement
23rd Dec 202411:03 amRNS-RStrategic Enhancements to the GATE Token Strategy
16th Dec 20249:24 amRNSSigning of a £2m binding option
16th Dec 20247:00 amRNSNon-binding Heads of Terms Signed To Raise £13m
20th Nov 20247:00 amRNSAdmission to Apex Segment of AQSE Growth Market
15th Nov 202410:58 amRNS-RAquis Showcase 2024 Retail Choice Award Winner
7th Oct 20247:00 amRNSIssue of Employee Share Options
30th Sep 20247:00 amRNSInterim Results
27th Sep 20247:00 amRNSLaunch of VLRM Capital Management
16th Sep 20247:00 amRNSIssuance of Digital Asset Service Provider Licence
14th Aug 20247:00 amRNSCollaboration with Fireblocks
29th Jul 20247:00 amRNSCollaboration with Tokeny
17th Jul 202410:00 amRNSAntier to Develop Valereum’s V-Wallet
5th Jul 20247:00 amRNSCompletion of £2 million Subscription
28th Jun 20244:59 pmRNSResults for the 12 months ended 31 December 2023
5th Jun 20243:33 pmRNSOTCQB Application Submitted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.